Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Search for safer and potent natural inhibitors of Parkinson's disease
Sidrah Tariq Khan, Sagheer Ahmed, Saima Gul, et al.
Neurochemistry International (2021) Vol. 149, pp. 105135-105135
Open Access | Times Cited: 22

Showing 22 citing articles:

A review on pathology, mechanism, and therapy for cerebellum and tremor in Parkinson’s disease
Yuke Zhong, Hang Liu, Guohui Liu, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 45
The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies
Ruhul Amin, Cristina Quispe, Anca Oana Docea, et al.
Neurochemistry International (2022) Vol. 158, pp. 105376-105376
Closed Access | Times Cited: 39
Combating Parkinson’s Disease with Plant-Derived Polyphenols: Targeting Oxidative Stress and Neuroinflammation
Reem M. Gahtani, Shoaib Shoaib, Umme Hani, et al.
Neurochemistry International (2024) Vol. 178, pp. 105798-105798
Closed Access | Times Cited: 10
Roles of clock genes in the pathogenesis of Parkinson's disease
Anastasiia D. Shkodina, Shing Cheng Tan, Mohammad Mehedi Hasan, et al.
Ageing Research Reviews (2021) Vol. 74, pp. 101554-101554
Closed Access | Times Cited: 54
Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach
Gurkaran Singh Baweja, Shankar Gupta, Bhupinder Kumar, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1823-1845
Open Access | Times Cited: 22
A recent update on drugs and alternative approaches for parkinsonism
Sneha Kispotta, Debajyoti Das, Shakti Ketan Prusty
Neuropeptides (2024) Vol. 104, pp. 102415-102415
Closed Access | Times Cited: 6
De Novo Production of Plant 4′-Deoxyflavones Baicalein and Oroxylin A from Ethanol in Crabtree-Negative Yeast
Zhilan Qian, Jiahui Yu, Xinjie Chen, et al.
ACS Synthetic Biology (2022) Vol. 11, Iss. 4, pp. 1600-1612
Closed Access | Times Cited: 24
An Overview of Methods for L-Dopa Extraction and Analytical Determination in Plant Matrices
Carmen Tesoro, Filomena Lelario, Rosanna Ciriello, et al.
Separations (2022) Vol. 9, Iss. 8, pp. 224-224
Open Access | Times Cited: 23
Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer’s Disease and Parkinson’s Disease
Aojie He, Meiling Wang, Xiaowan Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11054-11054
Open Access | Times Cited: 14
Targeting phosphodiesterase 4 as a potential therapy for Parkinson’s disease: a review
Pooja Devi Nongthombam, Reena Haobam
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Exploration of novel phytochemicals as α-synuclein aggregation inhibitors in the context of Parkinson’s disease therapy: an in-silico approach
Garima Gupta, Deepika Joshi, Gopeshwar Narayan, et al.
In Silico Pharmacology (2025) Vol. 13, Iss. 1
Closed Access
Research progress of plant‐derived natural alkaloids in central nervous system diseases
Qingqing Zhang, Qinghua Jiang, Kuiru Sa, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 4885-4907
Closed Access | Times Cited: 10
Programmable Biosynthesis of Plant‐Derived 4′‐Deoxyflavone Glycosides by an Unconventional Yeast Consortium
Yijia Kang, Zhilan Qian, Haishuang Yu, et al.
Small Methods (2024) Vol. 8, Iss. 8
Closed Access | Times Cited: 3
The Role of Exosomes in the Pathogenesis, Diagnosis, and Treatment of Parkinson's and Alzheimer's Diseases
Hami Reza Moradi, Sahar Abdollahinezhad, Sohrab Heydarian
The Neuroscience Journal of Shefaye Khatam (2024) Vol. 12, Iss. 2, pp. 87-101
Open Access | Times Cited: 3
Sophora alopecuroides Alleviates Neuroinflammation and Oxidative Damage of Parkinson’s Disease In Vitro and In Vivo
Ting Sun, Lei Chen, Rui Liu, et al.
The American Journal of Chinese Medicine (2023) Vol. 51, Iss. 02, pp. 309-328
Closed Access | Times Cited: 8
Nature as a source and inspiration for human monoamine oxidase B (hMAO-B) inhibition: A review of the recent advances in chemical modification of natural compounds
Francesco Melfi, Simone Carradori, Andrea Angeli, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 8, pp. 851-879
Closed Access | Times Cited: 8
Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the Caenorhabditis elegans Model
Ru‐Huei Fu, Syuan‐Yu Hong, Hui‐Jye Chen
Cells (2023) Vol. 12, Iss. 18, pp. 2310-2310
Open Access | Times Cited: 7
A Critical Overview of Enzyme-Based Electrochemical Biosensors for L-Dopa Detection in Biological Samples
Carmen Tesoro, Giuseppa Cembalo, Antonio Guerrieri, et al.
Chemosensors (2023) Vol. 11, Iss. 10, pp. 523-523
Open Access | Times Cited: 6
In silico study to identify new monoamine oxidase type a (MAO-A) selective inhibitors from natural source by virtual screening and molecular dynamics simulation
Khurshid Jalal, Kanwal Khan, Darakhshan Jabeen Haleem, et al.
Journal of Molecular Structure (2021) Vol. 1254, pp. 132244-132244
Closed Access | Times Cited: 12
A validated LC–MS/MS method for quantitative determination of L‐dopa in Fagioli di Sarconi beans (Phaseolus vulgaris L.)
Carmen Tesoro, Filomena Lelario, Rosanna Ciriello, et al.
Journal of Mass Spectrometry (2023) Vol. 58, Iss. 10
Open Access | Times Cited: 2
Development and Validation of Analytical Methods for Quantification of L-Dopa; Application to Plant Materials
Erten Akbel, İbrahim Bulduk
International Journal of Innovative Approaches in Agricultural Research (2023) Vol. 7, Iss. 2, pp. 208-219
Open Access
Parkinson’s Disease Treatment and the Role of Genetic Polymorphisms in the Efficacy and Adverse Effects
Halima Usman, Tooba Khalid, Amama Ghaffar
Precision Medicine Communications (2021) Vol. 1, Iss. 1, pp. 25-47
Open Access
Page 1

Scroll to top